| U.S. Personalized Medicine Market Share, Size, Demands, Key Company Analysis and Outlook 2027 |
|
| Personalized medicine or precision medicine is referred as the customization of treatment for an individual as per their genetic makeup and molecular profile. The ongoing research on its tools and its capacity in preventing mortality rates to unknown |
| read more |
|
|
| Medical Devices Market Analysis by Size, Share, Competitive Landscape and Developments Forecast 2027 |
|
| The global medical devices market is anticipated to procure a market value of USD 63423.6 million while expanding at a CAGR of 23.20% during the forecast period, evaluates Market Research Future (MRFR).The increasing development in medical technology |
| read more |
|
|
| Primary Aldosteronism Market to Exhibit Significant Opportunity Assessment Forecast to 2027 |
|
| Increasing prevalence of primary aldosteronism, growing geriatric population, rising number of obese individuals in the developing as well as the developed regions and increasing consumption of alcohol are estimated to drive the market growth during |
| read more |
|
|
| Transgenic Animals Market Growth Analysis, Current Status by Top Key Vendors and Trends 2027 |
|
| Transgenic animals or genetically modified (GM) animals have a foreign gene inserted into their DNA structure for various applications such as production of drugs, resistance to disease, and increasing yields. For instance, GM cows, sheep, and goats |
| read more |
|
|
| Malabsorption Syndrome Market Regional Data Analysis by Production, Price and Gross Margin by 2027 |
|
| A number of factors such as rising cases of causative diseases, unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising fund |
| read more |
|
|
| Nephroblastoma Treatment Market Demand for Create Robust Opportunities for Industry through 2027 |
|
| Nephroblastoma is the most common type of kidney cancer in children. The prevalence rate of nephroblastoma is about 9 out of 10 kidney cancers in children. Tumors which affects only one kidney and have only one tumor are unilateral. Around 5-10% of c |
| read more |
|
|
